Mastectomy is unnecessary

Radical mastectomy where the breast and surrounding muscles are removed is no better at preserving life than less aggressive treatments.

New research from the National Cancer Institute in Bethesda, Maryland, confirms that lumpectomy, where the breast is conserved, and radiation were just as effective after 10 years in controlling early stage (stage I and II) cancers.

Their findings, based on 247 patients, provide a further nail in the coffin of a surgical procedure developed 100 years ago by William Halsted. The shift away from this operation began 25 years ago, but it is now increasingly being seen as unnecessarily brutal.

The National Cancer Institute research found that 75 per cent of patients given mastectomy had survived, against 77 per cent of those given lumpectomy and radiation.

Their findings are welcome because another major study, published last year by the National Surgical Adjuvant Breast Project, came to the same conclusion, but was discredited because of fraudulent data (NEJM, April 6, 1995).

Related WDDTY Content

Breast cancer findings faked

The largest trial in the US on breast cancer which began the shift away from mastectomy as the preferred treatment was falsified (BMJ, 26 March 1994)....

Breast cancer-the unkindest cut

Most breast cancer surgeons engage in surgical overkill, and many safety questions surround the new wonder drugs. ... ...

Can Vitamin C be used as a Cancer therapy?

The US National Cancer Institute is taking a hard look at the effects of vitamin C on the body, particularly its alleged ability to treat cancer. ......

I beat my breast cancer through diet

I was shattered when I was told I had cancer. The doctor said I had to have a radical mastectomy on the right breast and a partial mastectomy on the l...

Proof of prevention

In order to see if supplementation with specific vitamins and minerals could lower cancer rates, a joint team from the US National Cancer Institute in...

Tamoxifen not effective for some breast cancers

Although BRCA2-positive women who use tamoxifen may be less likely to develop breast cancer than those using a placebo, BRCA1-positive women derive no...